HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

Direct-to-Consumer Shouldn't Always Mean Direct-To-Mail-Order: Why Fulfillment Choice Matters

Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines why direct-to-consumer strategies shouldn't default to mail-order as the endpoint for every program. She argues that preserving patient choice between retail pickup and home delivery can reduce fr

By Drug Channels · Jul 17, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
As outside experts gathered for a second day to discuss adding certain popular-yet-unapproved peptides to the …
Jul 26, 2026
The WeekFierceBiotech ↗
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
Jul 26, 2026
Tariffs, Korean biopharma M&A, and a Hong Kong-first IPO signal a more fragmented pharma market
The WeekBriefing
Three items stood out this week: U.S. import tariffs on generic drugs, Samsung Biologics pursuing a $1.8 billi…
Jul 26, 2026